Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials

Abstract

A discussion forum was hosted by the German not-for-profit Association for Applied Human Pharmacology (AGAH e.V.) to critically review key eligibility criteria and stopping rules for clinical trials with healthy subjects, enrolling stakeholders from the pharmaceutical industry, contract research organisations, academia, ethics committees and competent… (More)
DOI: 10.1007/s00228-016-2189-8

4 Figures and Tables

Topics

  • Presentations referencing similar topics